Back close

Dr. Nikhil Krishna Haridas

Assistant Professor, Department of Medical Oncology and Hematology, School of Medicine, Kochi

Qualification: DNB, MBBS, MD
nikhilkh@aims.amrita.edu

Bio

Dr. Nikhil Krishna Haridas is a highly qualified and experienced medical professional specializing in the field of oncology. He holds an impressive array of qualifications, including an MBBS, MD in General Medicine, and a DrNB in Medical Oncology. Additionally, he has earned the MRCP (UK) certification in Medical Oncology, as well as membership in the National Academy of Medical Sciences (India). Dr. Haridas has a rich work history, with significant contributions to the field of medical oncology.

His expertise spans a wide range of areas within oncology, with a particular focus on Genitourinary Oncology, including cancers of the prostate, bladder, kidney, and testicles. He is also well-versed in Molecular Oncology, Research Methodology, Clinical Trials, Palliative Medicine, and Quality of Life in cancer patients. Furthermore, he is known for his proficiency in administering high-dose chemotherapy with Autologous Stem Cell Rescue, particularly in the treatment of testicular cancer. With his extensive qualifications and experience, Dr. Nikhil Krishna Haridas plays a crucial role in advancing the field of medical oncology and providing comprehensive care to patients battling cancer.

Publications

Journal Article

Year : 2023

Prospective Evaluation of Response to Treatment, Survival Functions, Recurrence Pattern and Toxicity Profile in Indian Patients with Oligo-Brain Metastasis Treated with Only SRS

Cite this Research Publication : Dutta D, Reddy SK, Kamath RK, Sreenija Y, Nair H, Sashidharan A, Remesan Nair RA, Pushpuja KU, Kannan R, Edappattu A, Haridas NK, Jose WM, Keechilat P., "Prospective Evaluation of Response to Treatment, Survival Functions, Recurrence Pattern and Toxicity Profile in Indian Patients with Oligo-Brain Metastasis Treated with Only SRS," Neurol India. 2023 Jan-Feb;71(1):62-71. doi: 10.4103/0028-3886.370470. PMID: 36861576.

Publisher : Neurology India

Year : 2022

Outcomes of Granulocyte Transfusion in Haematology Patients with Febrile Neutropenia – a Single Centre Retrospective Cross Sectional Study

Cite this Research Publication : Gohul Gopi Jalajakumari, Rema Ganapathy, Veena Shenoy, Linda John, Manoj Unni, Nikhil Krishna Haridas, Syamprasad Vinayakumar, Chitresh Yadav, Shreya Gopal Agrawal, Rashmi Suresh Yawalkar, Sandeep Abhijit Pattnaik, Vandana Gopi, Neeraj Sidharthan, Arif Vaheedu Abdulvahid Ashya, Ajil Shaji, Nivedhitha Kartha; "Outcomes of Granulocyte Transfusion in Haematology Patients with Febrile Neutropenia - a Single Centre Retrospective Cross Sectional Study," Blood 2022; 140 (Supplement 1): 11384–11385. doi: https://doi.org/10.1182/blood-2022-170173

Publisher : Blood, ASH Publications

Year : 2022

Ruxolitinib for Myelofibrosis in Resource Limited Settings : A Slip between the Cup and the Lip

Cite this Research Publication : Karthika K V, Neeraj Sidharthan, Anjana K V, Remya Sudevan, Ullas Mony, Renjitha Bhaskaran, Manoj Unni, Rema Ganapathy, Nikhil Krishna Haridas; "Ruxolitinib for Myelofibrosis in Resource Limited Settings : A Slip between the Cup and the Lip," Blood 2022; 140 (Supplement 1): 5283–5284. doi: https://doi.org/10.1182/blood-2022-165537

Publisher : Blood, ASH Publications

Year : 2022

Light Chain(AL) Cardiac Amyloidosis: A Real World Data on Therapy and Outcomes

Cite this Research Publication : Sandeep Abhijit Pattnaik, Hisham Ahamed, Chitresh Yadav, Manoj Unni, Varsha K Rajeev, Vasundhara Raina, Nikhil Krishna Haridas, Rema Ganapathy, Mobin Paul, Ullas Mony, Neeraj Sidharthan, Damodhar Reddy Gouni, Rashmi Suresh Yawalkar, Shreya Gopal Agrawal, Gohul Gopi Jalajakumari; "Light Chain(AL) Cardiac Amyloidosis: A Real World Data on Therapy and Outcomes," Blood 2022; 140 (Supplement 1): 12578–12580. doi: https://doi.org/10.1182/blood-2022-169597

Publisher : Blood, ASH Publications

Year : 2022

Preventable Causes Dominate Mortality in Hemophilia : A Retrospective Observational Study from India

Cite this Research Publication : Shreya Gopal Agrawal, Shigy Francis, Vijaykumar Narayana Pillai, Manoj Unni, Rema Ganapathy, Nikhil Krishna Haridas, Chitresh Yadav, Rashmi Suresh Yawalkar, Sandeep Abhijit Pattnaik, Gohul Gopi Jalajakumari, Syamprasad Vinayakumar, Anjusha C, Neeraj Sidharthan; "Preventable Causes Dominate Mortality in Hemophilia : A Retrospective Observational Study from India," Blood 2022; 140 (Supplement 1): 7999–8000. doi: https://doi.org/10.1182/blood-2022-168972

Publisher : Blood, ASH Publications

Year : 2022

Fludrabine Treosulfan Conditioning Regimen Appears Safe and Effective in Patients with Acute Myeloid Leukemia(AML) and Myelodysplastic Syndrome (MDS) Undergoing Allogenic Hematopoietic Stem Cell Transplantation (HSCT)

Cite this Research Publication : Chitresh Yadav, Sharat Damodar, Rahul Bhargava, Nikhil Krishna Haridas, Ganesh S Jaishetwar, Mobin Paul, Bharath Ram S, Akshatha Nayak, Monisha Harimadhavan, Rohit Mangal, Manoj Unni, Rema Ganapathy, Rashmi Suresh Yawalkar, Shreya Gopal Agrawal, Ullas Mony, Nivedhitha Kartha, Neeraj Sidharthan; "Fludrabine Treosulfan Conditioning Regimen Appears Safe and Effective in Patients with Acute Myeloid Leukemia(AML) and Myelodysplastic Syndrome (MDS) Undergoing Allogenic Hematopoietic Stem Cell Transplantation (HSCT)," Blood 2022; 140 (Supplement 1): 12816–12818. doi: https://doi.org/10.1182/blood-2022-165555

Publisher : Blood, ASH Publications

Year : 2021

Melphalan 140 Mg/m 2 As Conditioning Regimen for Autologous Stem Cell Transplant- Comparative Study from a Tertiary Centre in Southern India

Cite this Research Publication : Sani Kodathumuriyil Sunny, Nikhil Krishna Haridas, Remya Sudevan, Ambily Nadaraj, Manoj Unni, Rema Ganapathy, Ullas Mony, Neeraj Sidharthan, "Melphalan 140 Mg/m 2 As Conditioning Regimen for Autologous Stem Cell Transplant- Comparative Study from a Tertiary Centre in Southern India," Blood, Volume 138, Supplement 1, 2021, Page 5024, ISSN 0006-4971, DOI: https://doi.org/10.1182/blood-2021-154371.

Publisher : Blood, Elsevier

Year : 2019

A Retrospective Study of the Clinico-pathological Profile of Primary Extra Nodal Lymphomas in a Tertiary Care Hospital

Cite this Research Publication : Babu, S. Janarthan, Nikhil Krishna, P. S. Dattatreya, S. S. Nirni, and Vindhya Vasini. "A Retrospective Study of the Clinico-pathological Profile of Primary Extra Nodal Lymphomas in a Tertiary Care Hospital." Global Journal of Hematology and Blood Transfusion6, no. 1 (2019): 1-5. http://dx.doi.org/10.15379/2408-9877.2019.06.01.01

Publisher : Global Journal of Hematology and Blood Transfusion

Qualification
  • DNB (Medical Oncology) under National Boards of Examination June 2019 Session
  • MD (General Medicine) at Academy of Medical Sciences Pariyaram Kerala under Kerala University of Health Sciences Thrissur, Kerala May 2014
  • MBBS at Jawaharlal Nehru Medical College Belgaum Karnataka under Rajiv Gandhi University of Health Science, Bangalore, Karnataka 2009
  • European Society of Medical Oncology (ESMO) Examination Certificate (ECMO) September 2021
  • Membership of Royal College of Physicians of the United Kingdom {MRCP(UK)} Specialty Certificate Examination in Medical Oncology 2022/01
  • Membership of National Academy of Medical Sciences (India) September 2022
Area of Expertise
  • Genitourinary Oncology with focus on Prostate, Bladder, Kidney and Testicular cancers., Molecular Oncology, Research Methodology, Clinical Trials, Palliative medicine and Quality of Life
  • High dose Chemotherapy with Autologous Stem Cell Rescue for Testicular cancer
Work Experience
  • Assistant Professor and Consultant, Department of Medical Oncology and Haematology/ Division of Stem Cell Transplant, Amrita Institute of Medical Sciences, Kochi (February 2020 – Present)
  • DNB Training Senior Resident in Medical Oncology at OMEGA Hospitals, Hyderabad- , Telangana from February 2016 to March 2019
  • Clinical Assistant Professor, Department of General Medicine, Amrita institute of Medical Sciences, Kochi from September 2014 to 20th February 2016
Admissions Apply Now